Thymosin alpha 1 in the treatment of cancer: from basic research to clinical application

This publication has 34 references indexed in Scilit:

• Thymosin- α 1 stimulates maturation of CD34+ stem cells into CD3+4+ cells in an in vitro thymic epithelia organ coculture model
  International Journal of Immunopharmacology, 1999
• Sequential chemoimmunotherapy for advanced non-small cell lung cancer using cisplatin, etoposide, thymosin-αl and interferon-α2a
  Published by Elsevier ,1995
• Immunotherapy with natural interleukins and/or thymosin α1 potently augments T-lymphocyte responses of hydrocortisone-treated aged mice
  International Journal of Immunopharmacology, 1995
• Combination treatment using thymosin α1 and interferon after cyclophosphamide is able to cure Lewis lung carcinoma in mice
  Cancer Immunology, Immunotherapy, 1990
• Thymosin alpha 1 modulates the expression of high affinity interleukin-2 receptors on normal human lymphocytes
  International Journal of Immunopharmacology, 1990
• Synergistic effect of thymosin α1 and αβ-interferon on NK activity in tumor-bearing mice
  International Journal of Immunopharmacology, 1989
• Characterization of the immunoregulatory properties of thymosin alpha 1 on interleukin-2 production and interleukin-2 receptor expression in normal human lymphocytes
  International Journal of Immunopharmacology, 1989
• Immunotherapy of cancer using interleukin 2: current status and future prospects
  Immunology Today, 1988
• A New Approach to the Adoptive Immunotherapy of Cancer with Tumor-Infiltrating Lymphocytes
  Science, 1986
• Thymosin α1 exerts protective effect against the 5-FU induced bone marrow toxicity
  International Journal of Immunopharmacology, 1985